Comparative Pharmacology
Head-to-head clinical analysis: DEXASPORIN versus HYDELTRASOL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXASPORIN versus HYDELTRASOL.
DEXASPORIN vs HYDELTRASOL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dexasporin is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It binds to the glucocorticoid receptor, leading to modulation of gene expression and inhibition of pro-inflammatory mediators such as prostaglandins and leukotrienes.
Corticosteroid with anti-inflammatory and immunosuppressive properties; suppresses multiple inflammatory cytokines and induces lipocortin synthesis.
1 to 2 mg/kg intramuscular or intravenous every 8 hours.
Intravenous: Initial dose 100-250 mg, then repeat every 10-30 minutes as needed. Intramuscular: 100-250 mg every 10-30 minutes. Intra-articular: 10-40 mg per joint every 1-2 weeks.
None Documented
None Documented
3-4 hours (prolonged to 10-15 hours in renal impairment; monitor CrCl <30 mL/min)
Terminal half-life ~2-3 hours; clinically, adrenal suppression may persist >24h.
Renal excretion (80-90% unchanged), biliary/fecal (10-20%)
Renally eliminated: ~80% as metabolites, <10% unchanged. Biliary/fecal: minor.
Category C
Category C
Corticosteroid/Antibiotic Combination
Corticosteroid